+$5.5M
Net Activity
Institutions Holding
98
Popularity Rank
#4488
Avg Weight
0.16%
Total Value
$346.0M
98 institutions currently hold NGNE, with 60 net buyers and 31 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
31
Net Buying Institutions
60
Top 5 by Value
+$130.0M
Total Buy Value
$62.5M
Total Sell Value
60
Net Buyers
31
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Neurogene Inc. signed an underwriting agreement on June 30, 2026 to sell 3.5 million shares of common stock at $30 per share and pre-funded warrants in a public offering. The underwriters exercised their option to buy additional shares, and the offering is expected to raise about $134.8 million in net proceeds. The deal is set to close on July 2, 2026.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter